Shopping Cart 0
Cart Subtotal
USD 0

United Kingdom Neurology Devices Market Outlook to 2023-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 5995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 11990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 17985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

United Kingdom Neurology Devices Market Outlook to 2023-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Summary

GlobalData's new report, "United Kingdom Neurology Devices Market Outlook to 2023", provides key market data on the United Kingdom Neurology Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Neurology Devices market categories-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the United Kingdom Neurology Devices market.

Key players covered include Medtronic plc, Boston Scientific Corp, St. Jude Medical LLC, LivaNova PLC and Others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Neurology Devices Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 11

3 Neurology Devices Market, United Kingdom 15

3.1 Neurology Devices Market, United Kingdom, Revenue ($m), 2009-2023 15

3.2 Neurology Devices Market, United Kingdom, Revenue ($m), 2009-2016 17

3.5 Neurology Devices Market, United Kingdom, Revenue ($m), 2016-2023 19

3.6 Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023 21

3.7 Neurology Devices Market, United Kingdom, Volume (Units), 2009-2016 23

3.8 Neurology Devices Market, United Kingdom, Volume (Units), 2016-2023 25

3.9 Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 27

4 CSF Management Market, United Kingdom 29

4.1 CSF Management Market, United Kingdom, Revenue Mix ($m), 2016 29

4.2 CSF Management Market, United Kingdom, Segment Contribution (%), 2016 30

4.3 CSF Management Market, United Kingdom, Revenue ($m), 2009-2016 31

4.4 CSF Management Market, United Kingdom, Revenue ($m), 2016-2023 33

4.5 CSF Management Market, United Kingdom, Volume (Units), 2009-2016 35

4.6 CSF Management Market, United Kingdom, Volume (Units), 2016-2023 37

4.7 CSF Management Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 39

4.8 CSF Management Market, United Kingdom, Company Share by Revenue ($m), 2016 40

5 Interventional Neurology Market, United Kingdom 42

5.1 Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2016 42

5.2 Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016 43

5.3 Interventional Neurology Market, United Kingdom, Revenue ($m), 2009-2016 45

5.4 Interventional Neurology Market, United Kingdom, Revenue ($m), 2016-2023 47

5.4.1 Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), by Segment, 2009-2016 49

5.4.2 Navigational System Market, United Kingdom, Revenue ($m), by Segment, 2009-2016 51

5.4.3 Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), by Segment, 2016-2023 53

5.4.4 Navigational System Market, United Kingdom, Revenue ($m), by Segment, 2016-2023 55

5.5 Interventional Neurology Market, United Kingdom, Volume (Units), 2009-2016 57

5.6 Interventional Neurology Market, United Kingdom, Volume (Units), 2016-2023 59

5.6.1 Embolization and Coiling Devices Market, United Kingdom, Volume (Units), by Segment, 2009-2016 61

5.6.2 Navigational System Market, United Kingdom, Volume (Units), by Segment, 2009-2016 63

5.6.3 Embolization and Coiling Devices Market, United Kingdom, Volume (Units), by Segment, 2016-2023 65

5.6.4 Navigational System Market, United Kingdom, Volume (Units), by Segment, 2016-2023 67

5.7 Interventional Neurology Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 69

5.8 Interventional Neurology Market, United Kingdom, Company Share by Revenue ($m), 2016 70

6 Neurological Diagnostic Equipment Market, United Kingdom 72

6.1 Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2016 72

6.2 Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016 73

6.3 Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), 2009-2016 74

6.4 Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), 2016-2023 76

6.5 Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), 2009-2016 78

6.6 Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), 2016-2023 80

6.7 Neurological Diagnostic Equipment Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 82

6.8 Neurological Diagnostic Equipment Market, United Kingdom, Company Share by Revenue ($m), 2016 83

7 Neurostimulation Devices Market, United Kingdom 85

7.1 Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2016 85

7.2 Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016 86

7.3 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2009-2016 87

7.4 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2016-2023 89

7.5 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2009-2016 91

7.6 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2016-2023 93

7.7 Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 95

7.8 Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 96

8 Neurosurgical Products Market, United Kingdom 98

8.1 Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2016 98

8.2 Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016 99

8.3 Neurosurgical Products Market, United Kingdom, Revenue ($m), 2009-2016 100

8.4 Neurosurgical Products Market, United Kingdom, Revenue ($m), 2016-2023 102

8.5 Neurosurgical Products Market, United Kingdom, Volume (Units), 2009-2016 104

8.6 Neurosurgical Products Market, United Kingdom, Volume (Units), 2016-2023 106

8.7 Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 108

8.8 Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), 2016 109

9 Radiosurgery Market, United Kingdom 111

9.1 Radiosurgery Market, United Kingdom, Revenue ($m), 2009-2016 111

9.2 Radiosurgery Market, United Kingdom, Revenue ($m), 2016-2023 113

9.3 Radiosurgery Market, United Kingdom, Volume (Units), 2009-2016 115

9.4 Radiosurgery Market, United Kingdom, Volume (Units), 2016-2023 117

10 Overview of Key Companies in United Kingdom, Neurology Devices Market 119

10.1 Medtronic Plc 119

10.1.1 Company Overview 119

10.2 B. Braun Melsungen AG 119

10.2.1 Company Overview 119

10.3 Stryker Corporation 119

10.3.1 Company Overview 119

10.4 DePuy Synthes Inc 119

10.4.1 Company Overview 119

10.5 KARL STORZ GmbH & Co KG 120

10.5.1 Company Overview 120

10.6 Integra LifeSciences Holdings Corp 120

10.6.1 Company Overview 120

10.7 Natus Medical Incorporated 120

10.7.1 Company Overview 120

10.8 Terumo Corp 120

10.8.1 Company Overview 120

10.9 St. Jude Medical LLC 121

10.9.1 Company Overview 121

10.10 LivaNova PLC 121

10.10.1 Company Overview 121

10.11 Boston Scientific Corp 121

10.11.1 Company Overview 121

10.12 Sophysa SA 121

10.12.1 Company Overview 121

11 Neurology Devices Market Pipeline Products 122

12 Financial Deals Landscape 126

12.1 Acquisition 126

12.1.1 Nestle Health Science to Acquire Phagenesis 126

12.2 Equity Offerings 127

12.2.1 Belluscura Raises USD0.7 Million in Second Tranche of Private Placement 127

12.3 Partnerships 128

12.3.1 York Instruments Enters into Agreement with eemagine Medical Imaging Solutions 128

12.3.2 GlaxoSmithKline to Form Joint Venture with Verily Life Sciences 129

12.4 Venture Financing 131

12.4.1 Cerus Endovascular Raises USD2.4 Million in Venture Financing 131

13 Recent Developments 132

13.1 Corporate Communications 132

13.1.1 Jun 19, 2017: GSK confirms start date for Luke Miels 132

13.1.2 Jun 15, 2017: Magstim Group Appoints Lothar Krinke as New CEO 132

13.1.3 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 132

13.1.4 May 24, 2017: Kamada Presents Updated Data from Phase 2 Clinical Trial of Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency at 2017 American Thoracic Society International Conference 132

13.1.5 May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer 134

13.1.6 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation 134

13.1.7 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK 134

13.1.8 Jan 19, 2017: Abbas Hussain to leave GSK 135

13.1.9 Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK 135

13.1.10 Jan 17, 2017: IXICO appoints Giulio Cerroni as Chief Executive Officer 136

13.1.11 Dec 19, 2016: GSK announces Board changes 136

13.1.12 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester 137

13.1.13 Oct 14, 2016: AorTech International Announces Board Changes 137

13.1.14 Sep 29, 2016: GlaxoSmithKline appoints Brian McNamara as CEO of GSK Consumer Healthcare 138

13.1.15 Sep 20, 2016: Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline 138

13.1.16 Sep 16, 2016: IXICO: Board Changes 138

13.1.17 Sep 16, 2016: Guy's and St Thomas' NHS Foundation Trust: New Non-Executive Director appointed 139

13.1.18 Aug 09, 2016: Guy's and St Thomas' appoints Chief Operating Officer 140

13.1.19 Aug 05, 2016: Two new Non-Executive Directors join the Board of Directors 140

13.1.20 Aug 01, 2016: LivaNova Names Chief Operating Officer 141

13.1.21 Jul 28, 2016: LivaNova Names Andrea L. Saia to its Board of Directors 141

13.1.22 Jul 27, 2016: BTG Announces Appointment of Non-executive Director 142

13.1.23 Jul 07, 2016: GSK and Save the Children call for developing country innovations to enter $1 million award 142

13.2 Financial Announcements 143

13.2.1 May 22, 2017: IXICO: Half Yearly Report to 31 March 2017 143

13.2.2 May 03, 2017: Casmed Reports First-Quarter 2017 Financial Results 143

13.2.3 May 03, 2017: LivaNova Reports First Quarter 2017 Results 144

13.2.4 Apr 26, 2017: GSK delivers another quarter of continued progress 145

13.2.5 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance 148

13.2.6 Mar 29, 2017: Cambridge Cognition Holdings: Preliminary Results for the year ended 31 December 2016 148

13.2.7 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results 148

13.2.8 Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016 150

13.2.9 Dec 21, 2016: AorTech International: Unaudited Interim Results For the six months ended 30 September 2016 164

13.2.10 Nov 15, 2016: BTG: Interim results 165

13.2.11 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results 166

13.2.12 Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016 167

13.2.13 Sep 29, 2016: LivaNova Announces Half-Year Financial Report 171

13.2.14 Sep 22, 2016: Cambridge Cognition Holdings: Half Yearly Report 178

13.2.15 Aug 15, 2016: AorTech International: Audited results for the year ended 31 March 2016 179

13.2.16 Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results 181

13.2.17 Jul 27, 2016: GlaxoSmithKline: Results announcement for the second quarter 2016 and half-yearly financial report for the half-year 2016 182

13.3 Government and Public Interest 196

13.3.1 Dec 02, 2016: Improving Alzheimers Disease Research with Digital Health Technology 196

13.3.2 Sep 28, 2016: New Clinical Study on NeuroEyeCoach Conclusively Supports Meaningful Improvement in Eye Movement Efficiency 196

13.4 Legal And Regulatory 197

13.4.1 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange 197

13.4.2 Dec 21, 2016: AorTech Shares Dive As Losses And Lawsuit Against Former CEO Continue 198

13.5 Other Significant Developments 198

13.5.1 Jun 07, 2017: Cambridge Cognition Holdings: Speech recognition for clinical trials 198

13.5.2 Apr 11, 2017: Stroke patients in England set to receive revolutionary new treatment 199

13.5.3 Dec 13, 2016: Magstim announces new distribution partnership in Netherlands 200

13.5.4 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 200

13.5.5 Oct 06, 2016: BTG: close period update 201

13.5.6 Sep 29, 2016: University of Glasgow to share in 17.7 million funding for new healthcare technologies research 201

13.5.7 Sep 29, 2016: Croton Healthcare Canada, York Instruments & Simon Fraser University Undertake Clinical Study Of MEG Effectiveness In Diagnosing Brain Concussions 202

13.5.8 Jul 27, 2016: GSK announces significant new investment in UK manufacturing network 203

13.5.9 Jul 14, 2016: BTG: Annual General Meeting 203

13.5.10 Jul 14, 2016: North Bristol NHS Trust wins innovation award to improve quality of health care 204

13.5.11 Jul 08, 2016: New funding for the harmonisation and alignment of brain imaging methods 205

13.6 Product News 205

13.6.1 May 18, 2017: Renishaw presents implant technology for oral and maxillofacial surgeons 205

13.6.2 Feb 23, 2017: Renishaw exhibiting at BioWales 2017 206

13.6.3 Jul 15, 2016: Alzheimers Association International Conference 2016 206

13.7 Strategy And Business Planning 207

13.7.1 Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms 207

13.7.2 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 207

13.7.3 Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization 208

14 Appendix 209

14.1 Research Methodology 210

14.1.1 Coverage 210

14.1.2 Secondary Research 210

14.1.3 Primary Research 211

14.1.4 Company Share Analysis 211

14.1.5 Distribution Share Analysis 211

14.1.6 Benchmarking 212

14.2 GlobalData Consulting 212

14.3 Contact Us 213

14.4 Disclaimer 213


List Of Figure

1.2 List of Figures

Figure 1: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023 15

Figure 2: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 17

Figure 3: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 19

Figure 4: Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023 21

Figure 5: Neurology Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 23

Figure 6: Neurology Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 25

Figure 7: Neurology Devices Market, United Kingdom, Company Share (%) 2016 27

Figure 8: CSF Management Market, United Kingdom, Revenue Mix ($m), 2016 29

Figure 9: CSF Management Market, United Kingdom, Segment Contribution (%), 2016 30

Figure 10: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 31

Figure 11: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 33

Figure 12: CSF Management Market, United Kingdom, Volume (Units), Historic, 2009-2016 35

Figure 13: CSF Management Market, United Kingdom, Volume (Units), Forecast, 2016-2023 37

Figure 14: CSF Management Market, United Kingdom, Company Share (%) 2016 40

Figure 15: Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2016 42

Figure 16: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016 43

Figure 17: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 45

Figure 18: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 47

Figure 19: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 49

Figure 20: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 51

Figure 21: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 53

Figure 22: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 55

Figure 23: Interventional Neurology Market, United Kingdom, Volume (Units), Historic, 2009-2016 57

Figure 24: Interventional Neurology Market, United Kingdom, Volume (Units), Forecast, 2016-2023 59

Figure 25: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 61

Figure 26: Navigational System Market, United Kingdom, Volume (Units), Historic, 2009-2016 63

Figure 27: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 65

Figure 28: Navigational System Market, United Kingdom, Volume (Units), Forecast, 2016-2023 67

Figure 29: Interventional Neurology Market, United Kingdom, Company Share (%) 2016 70

Figure 30: Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2016 72

Figure 31: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016 73

Figure 32: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 74

Figure 33: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 76

Figure 34: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Historic, 2009-2016 78

Figure 35: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Forecast, 2016-2023 80

Figure 36: Neurological Diagnostic Equipment Market, United Kingdom, Company Share (%) 2016 83

Figure 37: Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2016 85

Figure 38: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016 86

Figure 39: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 87

Figure 40: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 89

Figure 41: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 91

Figure 42: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 93

Figure 43: Neurostimulation Devices Market, United Kingdom, Company Share (%) 2016 96

Figure 44: Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2016 98

Figure 45: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016 99

Figure 46: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 100

Figure 47: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 102

Figure 48: Neurosurgical Products Market, United Kingdom, Volume (Units), Historic, 2009-2016 104

Figure 49: Neurosurgical Products Market, United Kingdom, Volume (Units), Forecast, 2016-2023 106

Figure 50: Neurosurgical Products Market, United Kingdom, Company Share (%) 2016 109

Figure 51: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 111

Figure 52: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 113

Figure 53: Radiosurgery Market, United Kingdom, Volume (Units), Historic, 2009-2016 115

Figure 54: Radiosurgery Market, United Kingdom, Volume (Units), Forecast, 2016-2023 117


List Of Table

1.1 List of Tables

Table 1: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023 16

Table 2: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 18

Table 3: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 20

Table 4: Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023 22

Table 5: Neurology Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 24

Table 6: Neurology Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 26

Table 7: Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 28

Table 8: CSF Management Market, United Kingdom, Segment Contribution (%), 2016 30

Table 9: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 32

Table 10: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Table 11: CSF Management Market, United Kingdom, Volume (Units), Historic, 2009-2016 36

Table 12: CSF Management Market, United Kingdom, Volume (Units), Forecast, 2016-2023 38

Table 13: CSF Management Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39

Table 14: CSF Management Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 41

Table 15: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016 44

Table 16: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 46

Table 17: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 48

Table 18: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 50

Table 19: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 52

Table 20: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 54

Table 21: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 56

Table 22: Interventional Neurology Market, United Kingdom, Volume (Units), Historic, 2009-2016 58

Table 23: Interventional Neurology Market, United Kingdom, Volume (Units), Forecast, 2016-2023 60

Table 24: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 62

Table 25: Navigational System Market, United Kingdom, Volume (Units), Historic, 2009-2016 64

Table 26: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 66

Table 27: Navigational System Market, United Kingdom, Volume (Units), Forecast, 2016-2023 68

Table 28: Interventional Neurology Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 69

Table 29: Interventional Neurology Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 71

Table 30: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016 73

Table 31: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 75

Table 32: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 77

Table 33: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Historic, 2009-2016 79

Table 34: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Forecast, 2016-2023 81

Table 35: Neurological Diagnostic Equipment Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 82

Table 36: Neurological Diagnostic Equipment Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 84

Table 37: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016 86

Table 38: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 88

Table 39: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 90

Table 40: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 92

Table 41: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 94

Table 42: Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 95

Table 43: Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 97

Table 44: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016 99

Table 45: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 101

Table 46: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 103

Table 47: Neurosurgical Products Market, United Kingdom, Volume (Units), Historic, 2009-2016 105

Table 48: Neurosurgical Products Market, United Kingdom, Volume (Units), Forecast, 2016-2023 107

Table 49: Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 108

Table 50: Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 110

Table 51: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 112

Table 52: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 114

Table 53: Radiosurgery Market, United Kingdom, Volume (Units), Historic, 2009-2016 116

Table 54: Radiosurgery Market, United Kingdom, Volume (Units), Forecast, 2016-2023 118

Table 55: Neurology Devices Market Pipeline Products 122

Table 56: Nestle Health Science to Acquire Phagenesis 126

Table 57: Belluscura Raises USD0.7 Million in Second Tranche of Private Placement 127

Table 58: York Instruments Enters into Agreement with eemagine Medical Imaging Solutions 128

Table 59: GlaxoSmithKline to Form Joint Venture with Verily Life Sciences 129

Table 60: Cerus Endovascular Raises USD2.4 Million in Venture Financing 131

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Neurology Devices, CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products, Radiosurgery, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, St. Jude Medical LLC, Boston Scientific Corp, DePuy Synthes Inc, LivaNova PLC, Stryker Corporation, Natus Medical Incorporated, Terumo Corp, Elekta AB, Integra LifeSciences Holdings Corp, B. Braun Melsungen AG, Nihon Kohden Corp, Accuray Inc, KARL STORZ GmbH & Co KG, MIZUHO Co., Ltd., W. L. Gore & Associates Inc, Sophysa SA


Companies

Medtronic Plc

B. Braun Melsungen AG

Stryker Corporation

DePuy Synthes Inc

KARL STORZ GmbH & Co KG

Integra LifeSciences Holdings Corp

Natus Medical Incorporated

Terumo Corp

St. Jude Medical LLC

LivaNova PLC

Boston Scientific Corp

Sophysa SA

United Kingdom Neurology Devices Market Outlook to 2023-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Summary

GlobalData's new report, "United Kingdom Neurology Devices Market Outlook to 2023", provides key market data on the United Kingdom Neurology Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Neurology Devices market categories-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the United Kingdom Neurology Devices market.

Key players covered include Medtronic plc, Boston Scientific Corp, St. Jude Medical LLC, LivaNova PLC and Others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Neurology Devices Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 11

3 Neurology Devices Market, United Kingdom 15

3.1 Neurology Devices Market, United Kingdom, Revenue ($m), 2009-2023 15

3.2 Neurology Devices Market, United Kingdom, Revenue ($m), 2009-2016 17

3.5 Neurology Devices Market, United Kingdom, Revenue ($m), 2016-2023 19

3.6 Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023 21

3.7 Neurology Devices Market, United Kingdom, Volume (Units), 2009-2016 23

3.8 Neurology Devices Market, United Kingdom, Volume (Units), 2016-2023 25

3.9 Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 27

4 CSF Management Market, United Kingdom 29

4.1 CSF Management Market, United Kingdom, Revenue Mix ($m), 2016 29

4.2 CSF Management Market, United Kingdom, Segment Contribution (%), 2016 30

4.3 CSF Management Market, United Kingdom, Revenue ($m), 2009-2016 31

4.4 CSF Management Market, United Kingdom, Revenue ($m), 2016-2023 33

4.5 CSF Management Market, United Kingdom, Volume (Units), 2009-2016 35

4.6 CSF Management Market, United Kingdom, Volume (Units), 2016-2023 37

4.7 CSF Management Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 39

4.8 CSF Management Market, United Kingdom, Company Share by Revenue ($m), 2016 40

5 Interventional Neurology Market, United Kingdom 42

5.1 Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2016 42

5.2 Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016 43

5.3 Interventional Neurology Market, United Kingdom, Revenue ($m), 2009-2016 45

5.4 Interventional Neurology Market, United Kingdom, Revenue ($m), 2016-2023 47

5.4.1 Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), by Segment, 2009-2016 49

5.4.2 Navigational System Market, United Kingdom, Revenue ($m), by Segment, 2009-2016 51

5.4.3 Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), by Segment, 2016-2023 53

5.4.4 Navigational System Market, United Kingdom, Revenue ($m), by Segment, 2016-2023 55

5.5 Interventional Neurology Market, United Kingdom, Volume (Units), 2009-2016 57

5.6 Interventional Neurology Market, United Kingdom, Volume (Units), 2016-2023 59

5.6.1 Embolization and Coiling Devices Market, United Kingdom, Volume (Units), by Segment, 2009-2016 61

5.6.2 Navigational System Market, United Kingdom, Volume (Units), by Segment, 2009-2016 63

5.6.3 Embolization and Coiling Devices Market, United Kingdom, Volume (Units), by Segment, 2016-2023 65

5.6.4 Navigational System Market, United Kingdom, Volume (Units), by Segment, 2016-2023 67

5.7 Interventional Neurology Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 69

5.8 Interventional Neurology Market, United Kingdom, Company Share by Revenue ($m), 2016 70

6 Neurological Diagnostic Equipment Market, United Kingdom 72

6.1 Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2016 72

6.2 Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016 73

6.3 Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), 2009-2016 74

6.4 Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), 2016-2023 76

6.5 Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), 2009-2016 78

6.6 Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), 2016-2023 80

6.7 Neurological Diagnostic Equipment Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 82

6.8 Neurological Diagnostic Equipment Market, United Kingdom, Company Share by Revenue ($m), 2016 83

7 Neurostimulation Devices Market, United Kingdom 85

7.1 Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2016 85

7.2 Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016 86

7.3 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2009-2016 87

7.4 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2016-2023 89

7.5 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2009-2016 91

7.6 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2016-2023 93

7.7 Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 95

7.8 Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 96

8 Neurosurgical Products Market, United Kingdom 98

8.1 Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2016 98

8.2 Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016 99

8.3 Neurosurgical Products Market, United Kingdom, Revenue ($m), 2009-2016 100

8.4 Neurosurgical Products Market, United Kingdom, Revenue ($m), 2016-2023 102

8.5 Neurosurgical Products Market, United Kingdom, Volume (Units), 2009-2016 104

8.6 Neurosurgical Products Market, United Kingdom, Volume (Units), 2016-2023 106

8.7 Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 108

8.8 Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), 2016 109

9 Radiosurgery Market, United Kingdom 111

9.1 Radiosurgery Market, United Kingdom, Revenue ($m), 2009-2016 111

9.2 Radiosurgery Market, United Kingdom, Revenue ($m), 2016-2023 113

9.3 Radiosurgery Market, United Kingdom, Volume (Units), 2009-2016 115

9.4 Radiosurgery Market, United Kingdom, Volume (Units), 2016-2023 117

10 Overview of Key Companies in United Kingdom, Neurology Devices Market 119

10.1 Medtronic Plc 119

10.1.1 Company Overview 119

10.2 B. Braun Melsungen AG 119

10.2.1 Company Overview 119

10.3 Stryker Corporation 119

10.3.1 Company Overview 119

10.4 DePuy Synthes Inc 119

10.4.1 Company Overview 119

10.5 KARL STORZ GmbH & Co KG 120

10.5.1 Company Overview 120

10.6 Integra LifeSciences Holdings Corp 120

10.6.1 Company Overview 120

10.7 Natus Medical Incorporated 120

10.7.1 Company Overview 120

10.8 Terumo Corp 120

10.8.1 Company Overview 120

10.9 St. Jude Medical LLC 121

10.9.1 Company Overview 121

10.10 LivaNova PLC 121

10.10.1 Company Overview 121

10.11 Boston Scientific Corp 121

10.11.1 Company Overview 121

10.12 Sophysa SA 121

10.12.1 Company Overview 121

11 Neurology Devices Market Pipeline Products 122

12 Financial Deals Landscape 126

12.1 Acquisition 126

12.1.1 Nestle Health Science to Acquire Phagenesis 126

12.2 Equity Offerings 127

12.2.1 Belluscura Raises USD0.7 Million in Second Tranche of Private Placement 127

12.3 Partnerships 128

12.3.1 York Instruments Enters into Agreement with eemagine Medical Imaging Solutions 128

12.3.2 GlaxoSmithKline to Form Joint Venture with Verily Life Sciences 129

12.4 Venture Financing 131

12.4.1 Cerus Endovascular Raises USD2.4 Million in Venture Financing 131

13 Recent Developments 132

13.1 Corporate Communications 132

13.1.1 Jun 19, 2017: GSK confirms start date for Luke Miels 132

13.1.2 Jun 15, 2017: Magstim Group Appoints Lothar Krinke as New CEO 132

13.1.3 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 132

13.1.4 May 24, 2017: Kamada Presents Updated Data from Phase 2 Clinical Trial of Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency at 2017 American Thoracic Society International Conference 132

13.1.5 May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer 134

13.1.6 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation 134

13.1.7 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK 134

13.1.8 Jan 19, 2017: Abbas Hussain to leave GSK 135

13.1.9 Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK 135

13.1.10 Jan 17, 2017: IXICO appoints Giulio Cerroni as Chief Executive Officer 136

13.1.11 Dec 19, 2016: GSK announces Board changes 136

13.1.12 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester 137

13.1.13 Oct 14, 2016: AorTech International Announces Board Changes 137

13.1.14 Sep 29, 2016: GlaxoSmithKline appoints Brian McNamara as CEO of GSK Consumer Healthcare 138

13.1.15 Sep 20, 2016: Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline 138

13.1.16 Sep 16, 2016: IXICO: Board Changes 138

13.1.17 Sep 16, 2016: Guy's and St Thomas' NHS Foundation Trust: New Non-Executive Director appointed 139

13.1.18 Aug 09, 2016: Guy's and St Thomas' appoints Chief Operating Officer 140

13.1.19 Aug 05, 2016: Two new Non-Executive Directors join the Board of Directors 140

13.1.20 Aug 01, 2016: LivaNova Names Chief Operating Officer 141

13.1.21 Jul 28, 2016: LivaNova Names Andrea L. Saia to its Board of Directors 141

13.1.22 Jul 27, 2016: BTG Announces Appointment of Non-executive Director 142

13.1.23 Jul 07, 2016: GSK and Save the Children call for developing country innovations to enter $1 million award 142

13.2 Financial Announcements 143

13.2.1 May 22, 2017: IXICO: Half Yearly Report to 31 March 2017 143

13.2.2 May 03, 2017: Casmed Reports First-Quarter 2017 Financial Results 143

13.2.3 May 03, 2017: LivaNova Reports First Quarter 2017 Results 144

13.2.4 Apr 26, 2017: GSK delivers another quarter of continued progress 145

13.2.5 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance 148

13.2.6 Mar 29, 2017: Cambridge Cognition Holdings: Preliminary Results for the year ended 31 December 2016 148

13.2.7 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results 148

13.2.8 Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016 150

13.2.9 Dec 21, 2016: AorTech International: Unaudited Interim Results For the six months ended 30 September 2016 164

13.2.10 Nov 15, 2016: BTG: Interim results 165

13.2.11 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results 166

13.2.12 Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016 167

13.2.13 Sep 29, 2016: LivaNova Announces Half-Year Financial Report 171

13.2.14 Sep 22, 2016: Cambridge Cognition Holdings: Half Yearly Report 178

13.2.15 Aug 15, 2016: AorTech International: Audited results for the year ended 31 March 2016 179

13.2.16 Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results 181

13.2.17 Jul 27, 2016: GlaxoSmithKline: Results announcement for the second quarter 2016 and half-yearly financial report for the half-year 2016 182

13.3 Government and Public Interest 196

13.3.1 Dec 02, 2016: Improving Alzheimers Disease Research with Digital Health Technology 196

13.3.2 Sep 28, 2016: New Clinical Study on NeuroEyeCoach Conclusively Supports Meaningful Improvement in Eye Movement Efficiency 196

13.4 Legal And Regulatory 197

13.4.1 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange 197

13.4.2 Dec 21, 2016: AorTech Shares Dive As Losses And Lawsuit Against Former CEO Continue 198

13.5 Other Significant Developments 198

13.5.1 Jun 07, 2017: Cambridge Cognition Holdings: Speech recognition for clinical trials 198

13.5.2 Apr 11, 2017: Stroke patients in England set to receive revolutionary new treatment 199

13.5.3 Dec 13, 2016: Magstim announces new distribution partnership in Netherlands 200

13.5.4 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 200

13.5.5 Oct 06, 2016: BTG: close period update 201

13.5.6 Sep 29, 2016: University of Glasgow to share in 17.7 million funding for new healthcare technologies research 201

13.5.7 Sep 29, 2016: Croton Healthcare Canada, York Instruments & Simon Fraser University Undertake Clinical Study Of MEG Effectiveness In Diagnosing Brain Concussions 202

13.5.8 Jul 27, 2016: GSK announces significant new investment in UK manufacturing network 203

13.5.9 Jul 14, 2016: BTG: Annual General Meeting 203

13.5.10 Jul 14, 2016: North Bristol NHS Trust wins innovation award to improve quality of health care 204

13.5.11 Jul 08, 2016: New funding for the harmonisation and alignment of brain imaging methods 205

13.6 Product News 205

13.6.1 May 18, 2017: Renishaw presents implant technology for oral and maxillofacial surgeons 205

13.6.2 Feb 23, 2017: Renishaw exhibiting at BioWales 2017 206

13.6.3 Jul 15, 2016: Alzheimers Association International Conference 2016 206

13.7 Strategy And Business Planning 207

13.7.1 Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms 207

13.7.2 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 207

13.7.3 Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization 208

14 Appendix 209

14.1 Research Methodology 210

14.1.1 Coverage 210

14.1.2 Secondary Research 210

14.1.3 Primary Research 211

14.1.4 Company Share Analysis 211

14.1.5 Distribution Share Analysis 211

14.1.6 Benchmarking 212

14.2 GlobalData Consulting 212

14.3 Contact Us 213

14.4 Disclaimer 213


List Of Figure

1.2 List of Figures

Figure 1: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023 15

Figure 2: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 17

Figure 3: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 19

Figure 4: Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023 21

Figure 5: Neurology Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 23

Figure 6: Neurology Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 25

Figure 7: Neurology Devices Market, United Kingdom, Company Share (%) 2016 27

Figure 8: CSF Management Market, United Kingdom, Revenue Mix ($m), 2016 29

Figure 9: CSF Management Market, United Kingdom, Segment Contribution (%), 2016 30

Figure 10: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 31

Figure 11: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 33

Figure 12: CSF Management Market, United Kingdom, Volume (Units), Historic, 2009-2016 35

Figure 13: CSF Management Market, United Kingdom, Volume (Units), Forecast, 2016-2023 37

Figure 14: CSF Management Market, United Kingdom, Company Share (%) 2016 40

Figure 15: Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2016 42

Figure 16: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016 43

Figure 17: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 45

Figure 18: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 47

Figure 19: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 49

Figure 20: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 51

Figure 21: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 53

Figure 22: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 55

Figure 23: Interventional Neurology Market, United Kingdom, Volume (Units), Historic, 2009-2016 57

Figure 24: Interventional Neurology Market, United Kingdom, Volume (Units), Forecast, 2016-2023 59

Figure 25: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 61

Figure 26: Navigational System Market, United Kingdom, Volume (Units), Historic, 2009-2016 63

Figure 27: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 65

Figure 28: Navigational System Market, United Kingdom, Volume (Units), Forecast, 2016-2023 67

Figure 29: Interventional Neurology Market, United Kingdom, Company Share (%) 2016 70

Figure 30: Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2016 72

Figure 31: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016 73

Figure 32: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 74

Figure 33: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 76

Figure 34: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Historic, 2009-2016 78

Figure 35: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Forecast, 2016-2023 80

Figure 36: Neurological Diagnostic Equipment Market, United Kingdom, Company Share (%) 2016 83

Figure 37: Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2016 85

Figure 38: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016 86

Figure 39: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 87

Figure 40: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 89

Figure 41: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 91

Figure 42: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 93

Figure 43: Neurostimulation Devices Market, United Kingdom, Company Share (%) 2016 96

Figure 44: Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2016 98

Figure 45: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016 99

Figure 46: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 100

Figure 47: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 102

Figure 48: Neurosurgical Products Market, United Kingdom, Volume (Units), Historic, 2009-2016 104

Figure 49: Neurosurgical Products Market, United Kingdom, Volume (Units), Forecast, 2016-2023 106

Figure 50: Neurosurgical Products Market, United Kingdom, Company Share (%) 2016 109

Figure 51: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 111

Figure 52: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 113

Figure 53: Radiosurgery Market, United Kingdom, Volume (Units), Historic, 2009-2016 115

Figure 54: Radiosurgery Market, United Kingdom, Volume (Units), Forecast, 2016-2023 117


List Of Table

1.1 List of Tables

Table 1: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023 16

Table 2: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 18

Table 3: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 20

Table 4: Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023 22

Table 5: Neurology Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 24

Table 6: Neurology Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 26

Table 7: Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 28

Table 8: CSF Management Market, United Kingdom, Segment Contribution (%), 2016 30

Table 9: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 32

Table 10: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Table 11: CSF Management Market, United Kingdom, Volume (Units), Historic, 2009-2016 36

Table 12: CSF Management Market, United Kingdom, Volume (Units), Forecast, 2016-2023 38

Table 13: CSF Management Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39

Table 14: CSF Management Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 41

Table 15: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016 44

Table 16: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 46

Table 17: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 48

Table 18: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 50

Table 19: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 52

Table 20: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 54

Table 21: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 56

Table 22: Interventional Neurology Market, United Kingdom, Volume (Units), Historic, 2009-2016 58

Table 23: Interventional Neurology Market, United Kingdom, Volume (Units), Forecast, 2016-2023 60

Table 24: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 62

Table 25: Navigational System Market, United Kingdom, Volume (Units), Historic, 2009-2016 64

Table 26: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 66

Table 27: Navigational System Market, United Kingdom, Volume (Units), Forecast, 2016-2023 68

Table 28: Interventional Neurology Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 69

Table 29: Interventional Neurology Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 71

Table 30: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016 73

Table 31: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 75

Table 32: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 77

Table 33: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Historic, 2009-2016 79

Table 34: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Forecast, 2016-2023 81

Table 35: Neurological Diagnostic Equipment Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 82

Table 36: Neurological Diagnostic Equipment Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 84

Table 37: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016 86

Table 38: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 88

Table 39: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 90

Table 40: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 92

Table 41: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 94

Table 42: Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 95

Table 43: Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 97

Table 44: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016 99

Table 45: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 101

Table 46: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 103

Table 47: Neurosurgical Products Market, United Kingdom, Volume (Units), Historic, 2009-2016 105

Table 48: Neurosurgical Products Market, United Kingdom, Volume (Units), Forecast, 2016-2023 107

Table 49: Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 108

Table 50: Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 110

Table 51: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 112

Table 52: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 114

Table 53: Radiosurgery Market, United Kingdom, Volume (Units), Historic, 2009-2016 116

Table 54: Radiosurgery Market, United Kingdom, Volume (Units), Forecast, 2016-2023 118

Table 55: Neurology Devices Market Pipeline Products 122

Table 56: Nestle Health Science to Acquire Phagenesis 126

Table 57: Belluscura Raises USD0.7 Million in Second Tranche of Private Placement 127

Table 58: York Instruments Enters into Agreement with eemagine Medical Imaging Solutions 128

Table 59: GlaxoSmithKline to Form Joint Venture with Verily Life Sciences 129

Table 60: Cerus Endovascular Raises USD2.4 Million in Venture Financing 131

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Neurology Devices, CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products, Radiosurgery, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, St. Jude Medical LLC, Boston Scientific Corp, DePuy Synthes Inc, LivaNova PLC, Stryker Corporation, Natus Medical Incorporated, Terumo Corp, Elekta AB, Integra LifeSciences Holdings Corp, B. Braun Melsungen AG, Nihon Kohden Corp, Accuray Inc, KARL STORZ GmbH & Co KG, MIZUHO Co., Ltd., W. L. Gore & Associates Inc, Sophysa SA


Companies

Medtronic Plc

B. Braun Melsungen AG

Stryker Corporation

DePuy Synthes Inc

KARL STORZ GmbH & Co KG

Integra LifeSciences Holdings Corp

Natus Medical Incorporated

Terumo Corp

St. Jude Medical LLC

LivaNova PLC

Boston Scientific Corp

Sophysa SA